NFIL3 has a high expression level in CD4+ T cells of patients with systemic lupus erythematosus (SLE) and suppresses the activation and self-reactivity of T cells and subsequent autoimmune response by downregulating CD40L (39). This evidence concerns the gene CD40LG and systemic lupus erythematosus.